Importantly, recent studies show that CIP2A is over-expressed in various human malignancies including head and neck squamous cell carcinoma (Junttila et al, 2007), oral squamous cell carcinoma (Basile and Czerninski, 2010), oesophageal squamous cell carcinoma (Qu et al, 2010), colon (Junttila et al, 2007), gastric (Li et al, 2008), breast (Come et al, 2009), prostate (Vaarala et al, 2010), tongue (Bockelman et al, 2011), lung (Dong et al, 2011; Ma et al, 2011), cervical cancer (Liu et al, 2011) and acute myeloid leukaemia (Wang et al, 2011). Here, CIP2A is linked to cervical carcinoma.